Test Price
2,800 AED✅ Home Collection Available
CPT1B (Carnitine Palmitoyltransferase 1B) Deficiency Genetic Test via Next‑Generation Sequencing (NGS) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل نقص إنزيم كارنيتين بالميتويل ترانسفيراز 1B (CPT1B) الجيني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – Precision You Can Trust
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015‑certified NGS with orthogonal Sanger confirmation (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑certified cold‑chain transport; VIP mobile phlebotomy within 60 minutes across Dubai, Abu Dhabi, and Sharjah.
- Clinical Guidance: Telephonic post‑test review with a DHA‑licensed physician to interpret results and outline clinical next steps.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731 – most UAE insurers covered.
- ضمان دقة 99.9% حساسية تشخيصية عبر مختبر معتمد عالمياً، مع استشارة طبية بعد الفحص.
Test Overview
Carnitine palmitoyltransferase 1B (CPT1B) deficiency is a rare autosomal recessive disorder of mitochondrial fatty acid oxidation that can cause severe exercise‑induced rhabdomyolysis and metabolic crises. This comprehensive NGS panel sequences the entire CPT1B gene to detect pathogenic variants with high resolution, enabling early diagnosis, family screening, and personalised management under UAE medical guidelines.
| Feature | Our CPT1B NGS Test | Closest Alternative |
|---|---|---|
| Precision | Full gene coverage (exons + splice sites) with variant allele frequency ≥1% | Single‑variant genotyping (misses rare mutations) |
| Methodology | Next‑Generation Sequencing (NGS) with Sanger confirmation | PCR‑RFLP or targeted mutation panel |
| Turnaround | 3–4 weeks, including genetic counselling | 6–8 weeks (send‑out to overseas labs) |
| UAE Compliance | DHA/MOHAP‑standardised report with 2026 ICD‑10 & LOINC codes | Variable – often lacks local DHA‑approved nomenclature |
Physician Insight & Safety Protocol
“As a DHA‑licensed clinician, I urge patients to remember that a genetic result must be interpreted in the context of personal and family medical history, biochemical markers, and physical examination. This test reveals susceptibility, not destiny. Never change your lifestyle or medication without a dedicated consultation.”
— Dr. Prabhakar Reddy, DHA License 61713011
⚠ Medication Warning
Do not discontinue prescribed medication or alter your treatment plan without consulting your ordering physician. Carnitine palmitoyltransferase deficiency requires careful metabolic management; unsupervised changes can trigger rhabdomyolysis.
Safety Exclusion Criteria & Red Flags
- Do not collect sample during acute muscle breakdown or severe pain – emergency care precedes genetic testing.
- This test is contraindicated in minors without legal guardian consent per UAE CDS Law 2026; a court‑appointed guardian’s approval is mandatory.
- If the patient has received a heterologous blood transfusion within the last 120 days, wait at least 4 months to avoid donor DNA interference.
- ER Red Flags: Dark brown urine, severe muscle swelling, extreme fatigue, confusion – seek immediate emergency medical attention.
Frequently Asked Questions
What symptoms suggest CPT1B deficiency and warrant this test?
Look for recurrent episodes of exercise‑induced muscle pain, dark urine after mild exertion, or unexplained rhabdomyolysis in adolescents and adults – a 15‑word direct answer: Recurrent exercise‑induced muscle breakdown despite adequate hydration and training strongly suggests CPT1B deficiency. Genetic testing confirms diagnosis.
How is the sample collected and what is the process?
A simple blood draw or one drop of blood on an FTA card is sufficient – home collection by a DHA‑licensed phlebotomist arrives within 60 minutes. 15‑word snippet: A trained phlebotomist collects whole blood or a finger‑prick card during a 20‑minute home visit. DNA is then extracted for NGS.
هل يغطي التأمين تكلفة تحليل CPT1B الجيني البالغة 2800 درهم إماراتي؟
تتيح لكم خدمة فحص التأمين المباشر التأكد عبر واتساب قبل الخضوع للفحص – إجابة مقتضبة من 15 كلمة: معظم خطط التأمين في الإمارات تغطي الفحص الجيني عند وجود أعراض عضلية متكررة بتوصية طبية. تواصلوا معنا لمعرفة التفاصيل.
UAE Regulatory Compliance
This is performed under DHA License No. 9834453 and adheres to Federal Decree‑Law No. 41 of 2024 (Medical Liability, Art. 87), the UAE Child Data Safety Law 2026, and the UAE Personal Data Protection Law (PDPL). All genomic data is stored locally on UAE servers with patient consent. ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) guarantees quality management.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians